Ilet was Beta Bionics’s largest product and service line in fiscal 2025, bringing in $52.75M of $100.25M (53%).
| Product and Service | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Ilet | $10.70M | $48.72M | $52.75M |
| Single-Use Products | $1.29M | $16.41M | $47.50M |
| Total | $12.00M | $65.12M | $100.25M |
Beta Bionics brought in $100.25M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 53.9% from $65.12M in fiscal 2024. Ilet was the largest at $52.75M (52.6%), ahead of Single-Use Products at $47.50M (47.4%).
Compared with fiscal 2024, Single-Use Products grew 189.5% to $47.50M and Ilet grew 8.3% to $52.75M. From fiscal 2023 to 2025, combined revenue from these lines grew from $12.00M to $100.25M, a compound annual growth rate of 189.1%. Ilet's share of the total fell from 89.2% to 52.6%.
Dme Channel was Beta Bionics’s largest revenue line in fiscal 2025, bringing in $75.82M of $100.25M (76%).
| Contract with Customer, Sales Channel | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Dme Channel | $11.26M | $58.81M | $75.82M |
| Pbp Channel | $735.00K | $6.32M | $24.43M |
| Total | $12.00M | $65.12M | $100.25M |
Beta Bionics brought in $100.25M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 53.9% from $65.12M in fiscal 2024. Dme Channel was the largest at $75.82M (75.6%), ahead of Pbp Channel at $24.43M (24.4%).
Compared with fiscal 2024, Pbp Channel grew 286.7% to $24.43M and Dme Channel grew 28.9% to $75.82M. From fiscal 2023 to 2025, combined revenue from these revenue lines grew from $12.00M to $100.25M, a compound annual growth rate of 189.1%. Dme Channel's share of the total fell from 93.9% to 75.6%.
Beta Bionics (BBNX) reports its revenue by product and service and by contract with customer, sales channel. In fiscal 2025, Ilet was its largest product and service line, bringing in $52.75M (52.6% of the total), followed by Single-Use Products at $47.50M (47.4%).
Ilet was Beta Bionics' largest product and service line in fiscal 2025, bringing in $52.75M, or 52.6% of the $100.25M total across its two product and service lines.
Dme Channel was Beta Bionics' largest revenue line in fiscal 2025, bringing in $75.82M, or 75.6% of the $100.25M total across its two revenue lines.
Single-Use Products grew faster than Ilet in fiscal 2025, up 189.5% from $16.41M to $47.50M. Ilet grew 8.3% to $52.75M.
Every figure comes from Beta Bionics' annual financial filings, as reported. Each line keeps the name Beta Bionics gives it, and years follow its fiscal calendar.
Beta Bionics' revenue by product and service goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.